3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
31
Burkitt Lymphoma
12
Recurrence
11
Lung Neoplasms
11
Leukemia, Myeloid, Acute
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Non-Hodgkin
8
Hodgkin Disease
8
Carcinoma, Non-Small-Cell Lung
7
Neuroblastoma
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Lymphoma, B-Cell
4
Leukemia
4
Wilms Tumor
3
Sarcoma, Ewing
3
Plasmablastic Lymphoma
3
Neoplasms, Germ Cell and Embryonal
3
Neoplasms
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, T-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Immunoblastic Lymphadenopathy
3
Ganglioneuroblastoma
3
Waldenstrom Macroglobulinemia
2
Interventions
Specimen Handling
4
Radiotherapy
4
Radiation
4
Nivolumab
4
pembrolizumab
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Doxorubicin
3
CTLA-4 Antigen
3
Biopsy
3
talimogene laherparepvec
1
peposertib
1
pazopanib
1
liposomal doxorubicin
1
fludarabine
1
cabozantinib
1
aldesleukin
1
X-Rays
1
Trabectedin
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Dactinomycin
1
Cyclophosphamide
1
BO-112
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Etoposide
×
90 days
×
Clear all
No trials found.